Introduction
Konjac Amorphophallus konjac K. Koch is a food plant that is rich in GlcCer. The efficacy of konjac GlcCer kGlcCer in trans-epidermal water loss in mice and humans has been studied by Uchiyama et al. 1 . However, it remains to be elucidated whether kGlCer and its metabolites may have a direct effect on itch-causing neurite outgrowth. Recently, we successfully prepared a homogenous extract of a plant-type ceramide using endoglycoceramidase I EGCase I , which was found in trace amounts in konjac extracts 2, 3 Fig. 1 . The resulting konjac ceramide kCer produced a weak apoptotic effect on PC12 cells compared to C2Cer. Unexpectedly, kCer possesses a neurite-outgrowth inhibitory effect that is absent in kGlcCer, C16Cer or C18Cer. In our previous study, the neurite-outgrowth activity of kCer was very similar to that of semaphorin3A Sema3A , and kCer also induces CRMP2 phosphorylation 2 .
In the peripheral nervous system and epidermis, Sema3A regulates itch sensations from undesired nerve fiber extensions of sensory neurons by reversing NGF activity 4, 5 . In the first step of cell signaling, at the cell surface, Sema3A acts with Nrp1, resulting in Sema3A pathway activation. We tested kCer binding to Nrp1 by cell surface Sema3A receptor assay and bio-layer interferometry BLI . In addition, Sema3A and kCer were tested synergy and competitive interactions included in dose-response effects relevant to inhibitory effects on neurite outgrowth and CRMP2 phosphorylation.
Experimental 2.1 General
The following materials were commercially obtained: 2.5S mouse NGF N100NF4325 and K252a SF2370 were purchased from Alomone Labs; semaphorin 3A Sema3A, 193-17051 from Wako Co.; neuropilin1 5994-N1-050 from R&D Systems; C2Cer, C16Cer, C18Cer, and C24Cer from Avanti Polar Lipids, anti-Nrp1 polyclonal antibody pAb αNrp1, SAB1411572, RRID:AB_ 09083 , anti-CRMP2 pAb C2993, RRID:AB_1078573 , and anti-phospho-CRMP2 pAb pthr509, SAB4504698, RRID:AB_118324 from SigmaAldrich; anti-GADPH 3E12 monoclonal antibody mAb LF-MA0100, RRID:AB_1874646 from Bioss. kCer was prepared in our laboratory, based on a published procedure 2 .
All experiments were performed by approval of Hokkaido University.
2.2 Cell culture, NGF-stimulation, and neurite outgrowth assay PC12 cells were grown in an incubator under 5 CO 2 at 37 . Neurite outgrowth experiment was performed using NGF-primed PC12 cells as previously described 2 . Prior to this neurite outgrowth experiment, NGF was dissolved in 0.025 bovine serum albumin BSA /DMEM containing kCer or other ceramides: C2Cer, C16Cer, C18Cer .
Western blot analysis
After treatment with kCer or other chemicals, PC12 cells were harvested for Western blot analysis as previously described 2 . CRMP2 and pCRMP2 were detected using primary antibodies, anti-CRMP2 1:2,000 , anti-pCRMP2 1:1,000 , and quantitated by blot normalization control GADPH.
RNA interference and transfection
Gene silencing was performed using siRNA. Nrp1-specific siRNA was purchased from Invitrogen RSS332427 with the sense strand sequence of 5 -GCACCUACAUCAU-CUUUGCACCAAA-3 . To evaluate the efficiency of knocking down Nrp1, scrambled siRNA medium GC Duplex, Invitrogen was used as a negative control. Transfection of siRNA was carried out using Lipofectamine TM 2000 Invitrogen, Grand Island, NY, USA according to the manufacturer s instructions. Briefly, siRNA and Lipofectamine TM 2000 reagent were mixed in Opti-MEM Invitrogen and incubated for 5 min at room temperature to allow complex formation. Cells were washed with Opti-MEM, and the transfection mixture was added. The cells were incubated for 6 h after transfection, washed, and cultured for 24 h in complete medium containing 10 FCS and 10 HS.
Receptor binding study using FITC-Sema3A
To investigate the binding of Sema3A to its receptor on After the microplate was incubated at 22 for 90 min, the wells were washed with 1 BSA in 10 mM HEPES buffer. Bound fluorescent activity was determined using a fluorescence microplate reader Appliskan TM , Thermo Fisher, Waltham, MA, USA with excitation and emission set at 490 and 525 nm, respectively. The ligand substitution experiment was performed using 10 μM FITC-Sema3A together with kCer, C16Cer, C18Cer, C24Cer, and C2Cer. Before addition, each Cer was dissolved in 0.3 BSA.
Bio-layer interferometry BLI
ForteBio BLItz TM Forte Bio, USA and nickel-nitrilotriacetic acid-coated Ni-NTA sensors were used for studying the interactions between Nrp1 and Sema3A or kCer, C16Cer, C18Cer, C24Cer, or C2Cer . Dulbecco s phosphate-buffered saline DPBS was used as the assay buffer for BLI, and the study was conducted at room temperature. Ni-NTA sensor tips were hydrated in buffer for 10 min prior to use. The shaker speed of the instrument was kept at 2,200 RPM. After a 40 s initial baseline step for obtaining stable baseline with DPBS, the sensor was loaded and saturated by soaking in a droplet of 0.6 μM Nrp1 for 120 s, followed by DPBS in the tube for 40 s custom and 180 s baseline steps. Subsequently, the association step was performed using droplets of Sema3A/BSA or kCer or other Cers for 120 s, followed by a 120 s dissociation step. As a reference experiment, a reference sensor was subjected to the same procedure, with BSA only. The association and dissociation responses were baseline-corrected using Octet Software Version 6.4, ForteBio, Fremont, CA, USA and exported to Scrubber Version 2.0 BioLogic Software Pty Ltd, Campbell, Australia . The individual signal responses at each concentration as well as the maximum responses R max were calculated as averages of three independent measurements.
The reproducibility of R max was determined with n 3. Interferometry data were globally fitted to a simple 1:1 Langmuir model calculating the affinities and rate constants Scrubber Version 2.0 . The association rate constant k a is defined as the rate of complex formation per second in a 1 molar solution of two reaction partners. The dissociation rate constant k d indicates the stability of this complex. The affinity constant K D is calculated as the ratio k d /k a . However, the k d can only be calculated if the curve fitting does not give convergence of any parameters due to highly nonspecific binding.
Statistical analysis
The number n in each experimental condition is indicated in the figure legends. Data analysis was performed using the commercial program Prism 4.0 GraphPad, San Diego, CA . When two experimental conditions were compared, statistical analysis was performed using a paired t test. Otherwise, statistical analysis was performed using one-way ANOVA followed by Tukey s Multiple Comparison post-test and Dunnett s test. A p value less than 0.05 was considered significant. indicates significantly different results. Ranges of p values are indicated in the figure legends. NS indicates non-significant. To evaluate the displacement reactivity of kCer and other ceramides C2Cer, C16Cer, C18Cer, and C24Cer , we performed an inhibition assay using 96-well microplates. As expected, kCer and Sema3A showed dose-dependent attenuation of the fluorescence intensity of FITC-Sema3A binding, as indicated by the following IC 50 values: kCer, 19 μM; Sema3A, 3.8 μM Table 1 . In contrast, other ceramides did not produce any displacement effect Fig. 3K .
Binding of kCer to Nrp1 is proved by BLI
To examine whether or not kCer possesses avidity to Nrp1, the binding of kCer to Nrp1 was tested using BLI. Diluted kCer and other ceramides C2Cer, C16Cer, C18Cer, and C24Cer were prepared in a 0.3 solution of BSA and compared to Sema3A. Individual association and dissociation curves are shown in Fig. 4 . Sema3A and kCer interacted in a concentration-dependent manner, but the kCer responses were a half-log-unit weaker than those for Sema3A. On the other hand, the other ceramides showed PC12 cells 1 10 5 were incubated with 10 μM FITC-Sema3A 32,100 RFU/pmol , which was then replaced with medium containing Sema3A at A: 0 μM, B: 1 μM, or C: 10 μM or with kCer at D: 0 μM, E: 10 μM, or F: 100 μM. siNRP1 gene-silenced PC12 cells were incubated with FITC-Sema3A, which was then replaced with medium containing Sema3A at G: 0 μM, or H: 10 μM, or kCer at I: 0 μM, or J: 100 μM. After washing, cells were observed by confocal laser microscopy FluoView FV10i, Olymus Corp., Tokyo, Japan . Scale bars are 100 μm. K: Cells were cultured in a 96-well microplate and treated with 32,100 RFU of FITC-Sema3A in the presence of Sema3A 0.05 to 10 μM , or kCer, C2Cer, C16Cer, C18Cer, or C24Cer 0.05 to 100 μM . After the cells were washed, the remaining fluorescence was determined using a fluorescence microplate reader with excitation and emission set at 490 and 525, respectively. Values of IC 50 and Ki were determined and are shown in Table 1 . The data are presented as the means and standard deviations of four individual experiments. 3.3 Combined effect of kCer and Sema3A on neurite outgrowth and pCRMP2 production To examine the combined effect of kCer and Sema3A, cells were treated with 0.01 to 10 μM Sema3A in the presence of three kCer concentrations 0.01, 5, and 25 μM Fig. 5A . As shown in Fig. 5B , 0.01 μM kCer showed no Table 2 . effect on neurite outgrowth inhibition by Sema3A. However, increasing the concentration of kCer from 5 to 25 μM resulted in an additional effect of kCer on low concentrations of 0.01 to 0.1 μM Sema3A, but kCer produced a reciprocal effect on high concentrations of 1 to 10 μM Sema3A the bottom right corner of Fig. 5A , and the right graph of Fig. 5B . We then examined this dose-dependent reciprocal effect on CRMP2 phosphorylation. As shown in Fig. 5C , cells treated with 0.01 μM kCer showed an increase in the pCRMP2/CRMP2 ratio in the presence of 0.1 to 10 μM Sema3A, but treatment with 5 or 25 μM kCer dampened this effect. These results suggest that kCer is an activator of Nrp1 at low concentrations of Sema3A but is an inhibitor of Nrp1 at high concentrations of Sema3A.
Discussion
In this study, we prepared konjac ceramide kCer using endoglycoceramidase I from konjac glucosylceramide 2 . We identified this plant ceramide as a potential Sema3A-like agonist that has a direct molecular interaction with Nrp1. Previously, we reported that kCer inhibited NGF from inducing neurite formation, accompanied by a Sema3A-like morphological change in the shape of PC12 cells in vitro 2 .
This process is considered to target the signaling pathway based on the finding that CRMP2 is also phosphorylated. The increase in CRMP2 phosphorylation directly translates into a decrease in the amount of CRMP2/microtubules binding, concomitant with an increase in neurite outgrowth. Through the activity of kCer identified herein, we were able to demonstrate inhibition of CRMP2-facilitated microtubule polymerization without a change in CRMP2 production. Consequently, NGF activity-induced neurite outgrowth might be prevented through kCer-driven inhibi- Fig. 2 . The displacement effect of kCer was compared with those of non-labeled Sema3A and the ceramides C2Cer, C16Cer, C18Cer, and C24Cer. As shown in Fig. 3 , kCer showed a specific displacement, while other ceramides showed no effect. In addition to the lack of effect on siNRP1-primed cells Figs. 3G, H, I and J , kCer showed 1/5-fold affinity Ki of 3 μM compared to Sema3A Although kCer was demonstrated to be a Sema3A-like agonist, the combined effect with Sema3A revealed Sema3A receptor antagonism in the presence of a high dose of Sema3A Fig. 5 . We suggest that this antagonism of kCer is receptor-mediated, given that kCer does not completely displace FITC-Sema3A binding even at 100 μM, as shown in Fig. 3K . Agonism at low doses of Sema3A and antagonism at high doses of Sema3A suggest that kCer may be a potential receptor regulator to control the Sema3A signaling pathway in both the central and peripheral nervous systems. These findings suggest that the Cer portion of konjac GlcCer may affect nerve endings and nerve fibers in the epidermis through the suppression of undesirable neurite extensions by NGF. Thus, kCer may have a beneficial effect in the treatment of hyperalgesia or uncontrolled itching, in particular atopic eczema.
Conclusion
We propose the following mechanism for kCer-mediated neurite outgrowth induction: kCer binds to Nrp1,resulting Nrp1/PlexA complex formation as a Sema3A agonist and activation of the Sema3A signaling pathway, resulting in neurite outgrowth inhibiton via CEMP2 phosphorylation and microtublues depolymerization. In addition, Agonism at low dose of Sema3A and antagonism at high dose of Sema3A, suggest that it may be due to the competition with kCer on the binding site of Nrp1 of Nrp1 of Sema3A. Sema3A binds to Nrp1, recruiting a monomer from an inactive PlexA dimer, resulting in the formation of a hetero-pentameric complex of Sema3A, Nrp1 dimer, and PlexA. Agonism at low dose of Sema3A and antagonism at high dose of Sema3A suggest that it may be due to competition with kCer on the binding site of Nrp1 of Sema3A.
